ICGC-ARGO precision medicine: familial matters in pancreatic cancer

Michèle Milella(National Cancer Institute), David K. Chang(University of Glasgow), Jean Abraham(Cancer Research UK), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Tatsuhiro Shibata(United Cerebral Palsy), Christian Pilarsky(University Hospital Carl Gustav Carus), Nikolajs Zeps, Khawla S. Al‐Kuraya(King Faisal Specialist Hospital & Research Centre), Keunchil Park(The University of Texas MD Anderson Cancer Center), Mark A. Rubin(University of Bern), Amber L. Johns(Garvan Institute of Medical Research), Steven Gallinger(Mount Sinai Hospital), Rita T. Lawlor(University of Verona), Raphael Koch(Harvard University), Sun-Soo Yoon, Rebecca C. Fitzgerald(Cancer Research UK), Lincoln Stein(Ontario Institute for Cancer Research), Claudio Luchini(University of Verona), Olivier Elemento(Cornell University), Takayuki Yoshino(University of Tsukuba), Wai Sang Poon(Prince of Wales Hospital), Jianmin Wu(Second Military Medical University), Marco A. Marra(University of British Columbia), Jan O. Korbel(European Bioinformatics Institute), David A. Tuveson(Cold Spring Harbor Laboratory), Paul M. Brennan(Radboud University Nijmegen), Raffaella Casolino(University of Verona), Carlos Caldas(University of Cambridge), Andrew V. Biankin(University of Glasgow), Eun Sook Lee(National Cancer Center), Xiaojian Wu(Sun Yat-sen University), Lorenz Trümper(University of Göttingen), Sergey I. Nikolaev(Inserm), Qimin Zhan(Peking University), Aldo Scarpa(University of Verona)
The Lancet Oncology
December 30, 2021
Cited by 9


Related Papers